Alignment Healthcare price to free cash flow ALHC
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Nov 2, 2026
- 19.0×
- Peer median
- 16.4×
Alignment Healthcare's price to free cash flow is 19.0× as of Nov 2, 2026.
The median for 10 healthcare stocks of a similar size is 16.4×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 19.0× | 8.8× | 38.3× |
| 2025 | 25.0× | 21.7× | 164× |
Against its peers
Companies in Healthcare nearest Alignment Healthcare's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ALHCAlignment Healthcare | 19.0× |
| PCRXPacira BioSciences | 8.1× |
| PNTGPennant | 40.8× |
| ANABAnaptysbio | n/m |
| HLFHerbalife | 4.3× |
| CNMDCONMED | 10.5× |
| PAHCPhibro Animal Health | 159× |
| EYENational Vision | 27.6× |
| CDRECadre | 17.3× |
| TRUPTrupanion | 16.4× |
| ANIPANI Pharmaceuticals | 9.4× |
| Peer median | 16.4× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Alignment Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.